MAPK3 and gastric cancer: We evaluated the expression of main downstream effectors of these two pathways, Erk1/2 and Akt, after stably introducing pCDNA3.1-ZIC1 to AGS, MKN28, BGC823 and SGC7901 gastric cancer cells (Figure 1A).